Rankings
▼
Calendar
OMER Q4 2023 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$835M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$205,000
Operating Income
-$40M
Net Income
-$9M
EPS (Diluted)
$-0.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$378M
Total Liabilities
$403M
Stockholders' Equity
-$25M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$205,000
$0
—
Operating Income
-$40M
-$40M
+0.9%
Net Income
-$9M
$129M
-107.0%
← FY 2023
All Quarters
Q1 2024 →